2024 Exhibitors Search
LUCASBIO
| Country | Korea, South |
|---|---|
| Address | |
| Tel (Rep.) | 02-532-2520 |
| Website | http://www.lucasbio.com |
Company Introduction
LucasBio Co., Ltd. Is a cell therapy company specializing in cell therapy manufacturing and research. LucasBio is simulataneously developing an immune cell therapy and stem cell therapy product to establish pipelines that can treat various intractable diseases, from cancer, viral infections, to immune-mediated inflammatory diseases. We have developed the first multi-antigen virus specific cell therapy with a simplified yet highly efficient manufacturing process. We aim to produce cell therapy at low costs to popularize cell therapy products to the public. In the future, LucasBio will continue to make efforts to develop novel cellular therapeutic agents by developing clear and effective technologies and promise to grow into a global cell therapy company.
Promotional video
Exhibit Item
GCLP based central lab analysis, cytokine-induced killer cell clinical study results, autologous COVID-19 antigen specific T cell clinical study results
Exhibit Item Images
-
Product Name : GCLP central lab analysisProviding high-quality clinical trial sample analysis services that meet the guidelines of domestic and international regulatory agencies for samples collected from clinical and non-clinical studies -
Product Name : cytokine-induced killer cell therapyAn autologous CD3+ CD56+ NK-like T cell-based therapy targeting minimal residual disease (MRD) -
Product Name : COVID-19 antigen specific T cell therapyAn autologous COVID-19 antigen-specific T cell therapy targeting patients with long-term COVID-19 infection
Exhibit Description
Co-Exhibitor or Partner’s Information
| Company Name | Country |
|---|---|
KYUNGYON EXHIBITION CORP.